Blood group A1 and A2 revisited: an immunochemical analysis |
| |
Authors: | L. Svensson,L. Rydberg,L. C. de Mattos,& S. M. Henry |
| |
Affiliation: | Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Göteborg University, Gothenburg, Sweden; Immunogenetics Laboratory, Department of Molecular Biology, Faculty of Medicine of São Josédo Rio Preto, Sao Paulo, Brazil; Biotechnology Research Institute, AUT University, and KODE Biotech Ltd, Auckland, New Zealand |
| |
Abstract: | Background and Objective The basis of blood group A1 and A2 phenotypes has been debated for many decades, and still the chemical basis is unresolved. The literature generally identifies the glycolipid chemical differences between blood group A1 and A2 phenotypes as being poor or no expression of A type 3 and A type 4 structures on A2 red cells, although this assertion is not unanimous. Materials and Methods Using purified glycolipids and specific monoclonal antibodies, we revisited the glycolipid basis of the A1 and A2 phenotypes. Purified glycolipids were extracted from four individual A1 and four individual A2 blood units. One blood unit from an A weak subgroup was also included. Monoclonal anti-A reagents including those originally used to define the basis of A1 and A2 phenotypes were used in a thin layer chromatography – enzyme immunoassay to identify the presence of specific glycolipids. Results A type 3 glycolipid structures were found to be present in large amounts in all phenotypes. In contrast, the A type 4 glycolipid structure was virtually undetectable in the A2 phenotype, but was present in the A1 and A subgroup samples. Conclusion The major glycolipid difference between the A1 and A2 phenotypes is the dominance of A type 4 glycolipids in the A1 phenotype. |
| |
Keywords: | ABO glycolipids immunochemical monoclonal antibody subgroups |
|
|